| Enzalutamide in metastatic prostate cancer before chemotherapy TM Beer, AJ Armstrong, DE Rathkopf, Y Loriot, CN Sternberg, CS Higano, ... New England Journal of Medicine 371 (5), 424-433, 2014 | 3602 | 2014 |
| Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable … T Wiegel, D Bottke, U Steiner, A Siegmann, R Golz, S Störkel, N Willich, ... Journal of Clinical Oncology 27 (18), 2924-2930, 2009 | 987 | 2009 |
| Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial T Powles, T Csőszi, M Özgüroğlu, N Matsubara, L Géczi, SYS Cheng, ... The Lancet Oncology 22 (7), 931-945, 2021 | 554 | 2021 |
| Adjuvant radiotherapy versus wait-and-see after radical prostatectomy: 10-year follow-up of the ARO 96–02/AUO AP 09/95 trial T Wiegel, D Bartkowiak, D Bottke, C Bronner, U Steiner, A Siegmann, ... European urology 66 (2), 243-250, 2014 | 507 | 2014 |
| Multinational, double-blind, phase III study of prednisone and either satraplatin or placebo in patients with castrate-refractory prostate cancer progressing after prior … CN Sternberg, DP Petrylak, O Sartor, JA Witjes, T Demkow, JM Ferrero, ... Journal of clinical oncology 27 (32), 5431-5438, 2009 | 400 | 2009 |
| Bicalutamide 150 mg plus standard care vs standard care alone for early prostate cancer DG McLEOD, P Iversen, WA See, T Morris, JON Armstrong, MP Wirth, ... BJU international 97 (2), 247-254, 2006 | 391 | 2006 |
| Perioperative complications of radical cystectomy in a contemporary series V Novotny, OW Hakenberg, D Wiessner, U Heberling, RJ Litz, ... European urology 51 (2), 397-402, 2007 | 383 | 2007 |
| The contemporary concept of significant versus insignificant prostate cancer G Ploussard, JI Epstein, R Montironi, PR Carroll, M Wirth, MO Grimm, ... European urology 60 (2), 291-303, 2011 | 376 | 2011 |
| Silodosin therapy for lower urinary tract symptoms in men with suspected benign prostatic hyperplasia: results of an international, randomized, double-blind, placebo-and active … CR Chapple, F Montorsi, TLJ Tammela, M Wirth, E Koldewijn, ... European urology 59 (3), 342-352, 2011 | 362 | 2011 |
| Radium-223 and concomitant therapies in patients with metastatic castration-resistant prostate cancer: an international, early access, open-label, single-arm phase 3b trial F Saad, J Carles, S Gillessen, A Heidenreich, D Heinrich, J Gratt, J Lévy, ... The Lancet Oncology 17 (9), 1306-1316, 2016 | 326 | 2016 |
| Prevention and management of complications following radical cystectomy for bladder cancer N Lawrentschuk, R Colombo, OW Hakenberg, SP Lerner, W Månsson, ... European urology 57 (6), 983-1001, 2010 | 308 | 2010 |
| European Association of Urology Guidelines Office Rapid Reaction Group: an organisation-wide collaborative effort to adapt the European Association of Urology guidelines … MJ Ribal, P Cornford, A Briganti, T Knoll, S Gravas, M Babjuk, C Harding, ... European urology 78 (1), 21-28, 2020 | 287 | 2020 |
| Bicalutamide as immediate therapy either alone or as adjuvant to standard care of patients with localized or locally advanced prostate cancer: first analysis of the early … WA See, MP Wirth, DG McLeod, P Iversen, I Klimberg, D Gleason, ... The Journal of urology 168 (2), 429-435, 2002 | 283 | 2002 |
| Aldehyde dehydrogenase is regulated by β-catenin/TCF and promotes radioresistance in prostate cancer progenitor cells M Cojoc, C Peitzsch, I Kurth, F Trautmann, LA Kunz-Schughart, ... Cancer research 75 (7), 1482-1494, 2015 | 269 | 2015 |
| Consensus statement of the European Urology Association and the European Urogynaecological Association on the use of implanted materials for treating pelvic organ prolapse and … CR Chapple, F Cruz, X Deffieux, AL Milani, S Arlandis, W Artibani, ... European urology 72 (3), 424-431, 2017 | 252 | 2017 |
| Bladder wall thickness in normal adults and men with mild lower urinary tract symptoms and benign prostatic enlargement OW Hakenberg, C Linne, A Manseck, MP Wirth Neurourology and Urodynamics: Official Journal of the International …, 2000 | 247 | 2000 |
| Bicalutamide 150 mg in addition to standard care in patients with localized or locally advanced prostate cancer: results from the second analysis of the early prostate cancer … MP Wirth, WA See, DG McLEOD, P Iversen, T Morris, K Carroll, ... The Journal of urology 172 (5), 1865-1870, 2004 | 244 | 2004 |
| Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised … T Powles, P Tomczak, SH Park, B Venugopal, T Ferguson, ... The lancet oncology 23 (9), 1133-1144, 2022 | 236 | 2022 |
| Early detection of prostate cancer: European Association of Urology recommendation A Heidenreich, PA Abrahamsson, W Artibani, J Catto, F Montorsi, ... European urology 64 (3), 347-354, 2013 | 235 | 2013 |
| Immunotherapy for metastatic renal cell carcinoma MP Wirth Urologic Clinics of North America 20 (2), 283-295, 1993 | 228 | 1993 |
